title: Botulinum toxin type B (Myobloc).
abstract: Myobloc, known as Neurobloc in Europe, is a member of the botulinum toxin family. It has been used for a myriad of problems since its approval in the United States in December 2000. It is currently not approved for cosmetic use but has been used for this purpose. This article reviews what is currently known about botulinum toxin type B and its efficacy and safety.
authors.affiliation: Division of Cosmetic Dermatology, University of Miami, Miami, Florida, USA.
authors.forename: Leslie
authors.initials: L
authors.lastname: Baumann
authors.forename: Laura
authors.initials: L
authors.lastname: Black
mesh_terms: D000818:Animals; D001905:Botulinum Toxins / Q000494:pharmacology / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A; D005145:Face; D006801:Humans; D006945:Hyperhidrosis / Q000188:drug therapy*; D009465:Neuromuscular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015595:Skin Aging / Q000187:drug effects*; D014103:Torticollis / Q000188:drug therapy*
chemical_list: D009465:Neuromuscular Agents; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A